The Role of Sphingolipid Metabolism in Pregnancy-Associated Breast Cancer After Chemotherapy
Our results may indicate the promising mechanism of placenta protection during chemotherapy for pregnant women with breast cancer and, consequently, of the newborn. This protective effect of the placenta and especially for the newborn has been discovered for the first time and requires more careful study.
Authors
- У. А. Гутнер (ORCID: https://orcid.org/0000-0001-5641-7452)
- Т. М. Заварыкина (ORCID: https://orcid.org/0000-0002-5993-6351)
- Elena V Kozyrko
- М. А. Капралова (ORCID: https://orcid.org/0000-0003-3010-3994)
- A. V. Alessenko (ORCID: https://orcid.org/0000-0002-1209-0133)
- Polina Lomskova
- V. E. Blokhin (ORCID: https://orcid.org/0000-0001-9074-7279)
- Е. В. Лузина (ORCID: https://orcid.org/0000-0002-8282-3056)
- Maria Shupik
- Darya Bajgazieva
- Vasily Kotsuba (ORCID: https://orcid.org/0000-0002-6992-7491)
- С. В. Хохлова (ORCID: https://orcid.org/0000-0002-4597-172X)
Institutions
- Russian Academy of Sciences (RU)
- Koltzov Institute of Developmental Biology (RU)
- National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I.Kulakov of the Ministry of Healthcare of the Russian Federation (RU)
- Federal Research Centre «Fundamentals of Biotechnology» of the Russian Academy of Sciences (RU)
- Institute of Biochemical Physics NM Emanuel (RU)
Publication Details
- Journal
- Biomedicines
- Published
- 2024-12-13
- DOI
- https://doi.org/10.3390/biomedicines12122843
- Primary Topic
- Sphingolipid Metabolism and Signaling
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Ministry of Science and Higher Education of the Russian Federation
- Russian Academy of Sciences